Previous study reported that PAI-1 gene 4G/4G in APL patients receiving ATRA treatment showed high PAI-1 level in vivo and increased the frequency of APL related thrombotic events [8]. This evidence concerns the gene SERPINE1 and acute promyelocytic leukemia.